ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,275.38
0.54%
Dow Jones
38,686.32
1.51%
Gold vs US Dollar
2,327.355
0.00%
Brent Oil
81.295
0.00%
Bitcoin
68,057.96
0.49%
Pepperstone
Advertisement
Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Anika Therapeutics Inc (ANIK)

  7. Anika Therapeutics Inc (ANIK) News

Anika Therapeutics (ANIK)

Anika Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ANIK
DateTimeSourceHeadlineSymbolCompany
30/05/202421:31Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:ANIKAnika Therapeutics Inc
28/05/202422:04Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ANIKAnika Therapeutics Inc
28/05/202421:05GlobeNewswire Inc.Anika Enters into Cooperation Agreement with Caligan PartnersNASDAQ:ANIKAnika Therapeutics Inc
08/05/202422:15Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ANIKAnika Therapeutics Inc
08/05/202421:12Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ANIKAnika Therapeutics Inc
08/05/202421:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ANIKAnika Therapeutics Inc
08/05/202421:08GlobeNewswire Inc.Anika Announces CFO TransitionNASDAQ:ANIKAnika Therapeutics Inc
08/05/202421:05GlobeNewswire Inc.Anika Reports First Quarter 2024 Financial ResultsNASDAQ:ANIKAnika Therapeutics Inc
03/05/202421:01GlobeNewswire Inc.Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:ANIKAnika Therapeutics Inc
18/04/202421:01GlobeNewswire Inc.Anika to Issue First Quarter 2024 Financial Results on Wednesday, May 8, 2024NASDAQ:ANIKAnika Therapeutics Inc
02/04/202413:00GlobeNewswire Inc.Anika to Participate in the 23rd Annual Needham Virtual Healthcare ConferenceNASDAQ:ANIKAnika Therapeutics Inc
13/03/202420:05GlobeNewswire Inc.Anika Reports Fourth Quarter and Year-End 2023 Financial ResultsNASDAQ:ANIKAnika Therapeutics Inc
13/03/202411:03IH Market NewsMixed Futures Amidst Quiet Economic Schedule; Oil Prices ClimbNASDAQ:ANIKAnika Therapeutics Inc
08/03/202421:01GlobeNewswire Inc.Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:ANIKAnika Therapeutics Inc
07/03/202400:30Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:ANIKAnika Therapeutics Inc
27/02/202421:01GlobeNewswire Inc.Anika to Issue Fourth Quarter and Year-End 2023 Financial Results on Wednesday, March 13, 2024NASDAQ:ANIKAnika Therapeutics Inc
26/02/202414:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ANIKAnika Therapeutics Inc
13/02/202414:00GlobeNewswire Inc.Anika Highlights Its Recently Launched Integrity™ Implant System and RevoMotion™ Reverse Shoulder Arthroplasty System Along with Other Key Regenerative Products During the 2024 AAOS Annual MeetingNASDAQ:ANIKAnika Therapeutics Inc
09/02/202416:09Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:ANIKAnika Therapeutics Inc
24/01/202419:27Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:ANIKAnika Therapeutics Inc
22/01/202414:29Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:ANIKAnika Therapeutics Inc
19/01/202421:52Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:ANIKAnika Therapeutics Inc
12/01/202421:35Edgar (US Regulatory)Form 3/A - Initial statement of beneficial ownership of securities: [Amend]NASDAQ:ANIKAnika Therapeutics Inc
28/11/202314:00GlobeNewswire Inc.Anika Announces First Surgeries Performed using the Integrity™ Implant System, a Regenerative Hyaluronic Acid-Based Patch System for Rotator Cuff Repairs, Commencing Limited Market ReleaseNASDAQ:ANIKAnika Therapeutics Inc
07/11/202321:05GlobeNewswire Inc.Anika to Participate in Upcoming Investor ConferencesNASDAQ:ANIKAnika Therapeutics Inc
02/11/202320:11Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ANIKAnika Therapeutics Inc
02/11/202320:05GlobeNewswire Inc.Anika Reports Third Quarter 2023 Financial Results and Raises Full-Year 2023 Financial Guidance on Growing Momentum Across the BusinessNASDAQ:ANIKAnika Therapeutics Inc
10/10/202314:00GlobeNewswire Inc.Anika to Issue Third Quarter 2023 Financial Results on Thursday, November 2, 2023NASDAQ:ANIKAnika Therapeutics Inc
03/10/202321:31Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANIKAnika Therapeutics Inc
21/09/202312:55Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ANIKAnika Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:ANIK

Your Recent History

USOTC
BVILF
Breville (PK)
NYSE
NCV
Virtus Convertible and I...
BIT
P215I2
NLBNPIT215I2 20241220 420
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved